Amyloidosis comprises a group of diseases characterized by the extracellular deposition of
insoluble fibrillar proteins. This mechanism generates different clinical syndromes depending …

Amyloidosis comprises a unique group of diseases that share in common the extracellular
deposition of insoluble fibrillar proteins in organs and tissue including the heart. Cardiac …

Objective. Through a systematic literature search (SLR) and metaanalysis, to determine
maternal and fetal outcomes in pregnancies involving systemic sclerosis (SSc), to analyze the …

Aim The importance of right ventricle (RV) dysfunction in AL amyloidosis has been underestimated.
This study was designed to comprehensively evaluate RV function and its prognostic …

Objective The aim of this study was to identify the main CT features that may help in
distinguishing a progression of interstitial lung disease (ILD) secondary to SSc from COVID-19 …

Objectives Cardiac rhythm disturbances constitute the most frequent cardiovascular cause
of death in SSc. However, electrocardiographic findings are not a part of risk stratification in …

Background Cardiac involvement is a relevant clinical finding in systemic sclerosis (SSc) and
is associated with poor prognosis. Left atrial (LA) remodeling and/or dysfunction can be an …

Background Few studies have analyzed the clinical and echocardiographic differences
between light‐chain ( AL ) and transthyretin ( TTR ) amyloidosis. Hypothesis The aim of the …

Early COVID-19 treatments can prevent progression to severe disease. However, real-life
data are still limited, and studies are warranted to monitor the efficacy and tolerability of these …

Introduction Intravenous immunoglobulins (IVIG) are a new therapeutic approach in systemic
sclerosis SSc. An immunomodulatory and antifibrotic activity has been postulated. IVIG are …